Price
Target price
€8.52
€8.52
-0.580%
-0.05
-0.580%
€10.82
23.08.24 / Tradegate
WKN: A0LC2W / Symbol: EBS / Name: Emergent Bio / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Emergent Biosolutions Inc. Stock
The price for the Emergent Biosolutions Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.050 (-0.580%).
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 10 € shows a slightly positive potential of 17.43% compared to the current price of 8.52 € for Emergent Biosolutions Inc..
For the coming years our community has positive and negative things to say abot the Emergent Biosolutions Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | -0.580% | -12.459% | -26.108% | 104.417% | 282.226% | -84.294% | -77.306% |
| Ironwood Pharmaceuticals | -5.380% | 7.653% | -33.016% | -50.059% | -58.627% | -61.982% | -45.351% |
| Arrowhead Pharmaceuticals Inc. | 0.730% | 7.427% | -16.554% | -15.983% | -21.413% | -58.166% | -20.180% |
| Novocure Ltd | 0.650% | -0.770% | -6.881% | -41.606% | 12.820% | -86.008% | -80.601% |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat